Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

4 analysts have shared their evaluations of Collegium Pharmaceutical COLL during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot ...

Investors eyeing a purchase of Collegium Pharmaceutical Inc (Symbol: COLL) stock, but cautious about paying the going market price of $35.97/share, might benefit from considering selling puts ...

STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of ...

The SC collegium called the Centre’s objection based on a Kerala HC judge’s alleged political affiliation as “extremely vague” ...

Collegium Pharmaceutical (COLL) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.

NEW DELHI: Despite being notified six months ago, the collegium system in AIIMS New Delhi is yet to be implemented properly. Sources said that over 80% of the departments at the institute have not ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...